22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
  • News

  • Press Releases
Jun 14, 2019 11:00am EDT

22nd Century Group Appoints Michael J. Zercher as Chief Operating Officer

May 07, 2019 4:20pm EDT

22nd Century Files 2019 First Quarter Report and Announces Conference Call to Provide Business Update

Apr 30, 2019 9:50am EDT

22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection

Apr 18, 2019 1:15pm EDT

Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders

Apr 17, 2019 9:45am EDT

22nd Century Group Hires Former Imperial Brands Head of Regulatory Science

Apr 09, 2019 8:05am EDT

22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis

Mar 28, 2019 9:45am EDT

22nd Century Group Issues Annual Letter to Shareholders

Mar 27, 2019 9:00am EDT

22nd Century’s New Study Confirms Very Low Nicotine Content Cigarettes Result in 97% Less Nicotine in Smoker’s Bloodstream

Mar 06, 2019 4:15pm EST

22nd Century Files 2018 Annual Report and Announces Conference Call to Provide Business Update

Dec 27, 2018 1:02pm EST

22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes

RSS
  • Prev
    • 1...
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • ...35
    Next
    • Email Alerts
    • Contact
    • RSS News Feed
    © 2022 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy / CCPA Disclaimer Sitemap